77 related articles for article (PubMed ID: 4537361)
1. [Supplemental studies on amphotericin B].
Fukaya K
Jpn J Antibiot; 1972 Feb; 25(1):17-20. PubMed ID: 4537361
[No Abstract] [Full Text] [Related]
2. [Candida in feces following oral administration of premixed tetracycline and amphotericin B preparation].
Fukaya K; Kitamoto O
Kansenshogaku Zasshi; 1970 Jan; 43(10):283-8. PubMed ID: 4985501
[No Abstract] [Full Text] [Related]
3. The effect of amphotericin B on the fungal flora in feces.
Bodey GP
Clin Pharmacol Ther; 1969; 10(5):675-80. PubMed ID: 5817629
[No Abstract] [Full Text] [Related]
4. [The effects of the administration of tetracycline-amphotericin B (Amphocycline) capsules on the growth of Candida in the feces].
Watanabe K; Ikemoto H
Jpn J Antibiot; 1969 Apr; 22(2):155-8. PubMed ID: 5306451
[No Abstract] [Full Text] [Related]
5. [Incidence of Candida albicans in infant oral materials and feces, and the sensitivity of amphotericin B to them].
Hashimoto Y; Okuda K; Kametani H; Okumura S; Yonezawa W
Shikwa Gakuho; 1972 Mar; 72(3):762-6. PubMed ID: 4556676
[No Abstract] [Full Text] [Related]
6. In vitro susceptibility and resistance of Candida spp. to hamycin.
Athar MA
Sabouraudia; 1971 Nov; 9(3):256-62. PubMed ID: 4944203
[No Abstract] [Full Text] [Related]
7. Candidemia caused by amphotericin B and fluconazole resistant Candida auris.
Sarma S; Kumar N; Sharma S; Govil D; Ali T; Mehta Y; Rattan A
Indian J Med Microbiol; 2013; 31(1):90-1. PubMed ID: 23508441
[No Abstract] [Full Text] [Related]
8. Amphotericin B-induced in vitro postantifungal effect on Candida species of oral origin.
Ellepola AN
Med Princ Pract; 2012; 21(5):442-6. PubMed ID: 22678101
[TBL] [Abstract][Full Text] [Related]
9. EUCAST technical note on Amphotericin B.
Lass-Flörl C; Arendrup MC; Rodriguez-Tudela JL; Cuenca-Estrella M; Donnelly P; Hope W;
Clin Microbiol Infect; 2011 Dec; 17(12):E27-9. PubMed ID: 22011310
[TBL] [Abstract][Full Text] [Related]
10. Susceptibilities to amphotericin B and fluconazole of Candida species in Taiwan Surveillance of Antimicrobial Resistance of Yeasts 2006.
Yang YL; Wang AH; Wang CW; Cheng WT; Li SY; Lo HJ;
Diagn Microbiol Infect Dis; 2008 Jun; 61(2):175-80. PubMed ID: 18304773
[TBL] [Abstract][Full Text] [Related]
11. [Sensitivity of fungi in the genus Candida to antimicrobial preparations].
Paliĭ GK; Ivanova SA
Antibiot Med Biotekhnol; 1986 Mar; 31(3):218-20. PubMed ID: 2940962
[TBL] [Abstract][Full Text] [Related]
12. Prolonged oral treatment of chronic mucocutaneous candidiasis with Amphotericin B.
Montes LF; Cooper MD; Bradford LG; Lauderdale RO; Taylor CD
Arch Dermatol; 1971 Jul; 104(1):45-56. PubMed ID: 5120161
[No Abstract] [Full Text] [Related]
13. [Minimum inhibitory concentration of amphotericin B in yeasts of medical interest].
Fernández Andreu CM; González Miranda M; Illnait Zaragozí MT; Martínez Machín G
Rev Cubana Med Trop; 1998; 50(1):48-53. PubMed ID: 9842268
[TBL] [Abstract][Full Text] [Related]
14. Chitosan-coated antifungal formulations for nebulisation.
Albasarah YY; Somavarapu S; Stapleton P; Taylor KM
J Pharm Pharmacol; 2010 Jul; 62(7):821-8. PubMed ID: 20636869
[TBL] [Abstract][Full Text] [Related]
15. Therapies against murine Candida guilliermondii infection, relationship between in vitro antifungal pharmacodynamics and outcome.
Paredes K; Pastor FJ; Capilla J; Sutton DA; Mayayo E; Fothergill AW; Guarro J
Rev Iberoam Micol; 2015; 32(1):34-9. PubMed ID: 24594291
[TBL] [Abstract][Full Text] [Related]
16. A modified agar diffusion assay for amphotericin B.
Cosgrove RF; Jones GT
J Pharm Pharmacol; 1978 May; 30(5):334-5. PubMed ID: 26759
[No Abstract] [Full Text] [Related]
17. [In vitro sensitivity to 5-fluorocytosine and amphotericin B of yeasts of the Candida genus isolated in Barcelona].
Torres-Rodríguez JM; Sabaté M; Gallach C; Carrillo A; Madrenys N
Enferm Infecc Microbiol Clin; 1990 Feb; 8(2):91-3. PubMed ID: 2098147
[TBL] [Abstract][Full Text] [Related]
18. Concentrations of amphotericin B in faeces and blood of healthy volunteers after the oral administration of various doses.
Hofstra W; de Vries-Hospers HG; van der Waaij D
Infection; 1982; 10(4):223-7. PubMed ID: 7129644
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of amphotericin B against Candida lusitaniae clinical isolates.
Prigitano A; Biraghi E; Pozzi C; Viviani MA; Tortorano AM
J Chemother; 2010 Feb; 22(1):71-2. PubMed ID: 20227999
[No Abstract] [Full Text] [Related]
20. Synergistic effect of amphotericin B and tyrosol on biofilm formed by Candida krusei and Candida tropicalis from intrauterine device users.
Shanmughapriya S; Sornakumari H; Lency A; Kavitha S; Natarajaseenivasan K
Med Mycol; 2014 Nov; 52(8):853-61. PubMed ID: 25202127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
